title: Anti-thyroid peroxidase antibody in vitiligo: a prevalence study.
abstract: Aim. The aim of the study was to study the relation of vitiligo with demographic data like age, sex, and duration and determine the prevalence of thyroid autoimmunity in vitiligo patients. Materials and Methods. This study was a cross sectional study consisting of 100 patients clinically diagnosed (old and new) as having vitiligo irrespective of age or sex. Patients with known thyroid disease on supplementation therapy, or who had undergone thyroid surgery, those on antithyroid medication, patients with other causes of leukoderma, and cases who do not provide informed consent were excluded from the study. Serum TSH and anti-TPO antibodies were measured in all the patients. Results. The prevalence of anti-TPO antibody positivity was found to be 28%. Conclusion. According to our study, none of our vitiligo patients had symptoms or signs of thyroid disease at the time of presentation but, on biochemical evaluation, anti-TPO antibodies were found in a considerable number of patients. Hence, we recommend screening of these patients with thyroid antibodies.
authors: Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College and Dr. Prabhakar Kore KLES Hospital, Belgaum, Karnataka 590010, India.
authors: R
authors: R
authors: Dash
authors: The INCLEN Trust International, New Delhi 110020, India.
authors: A
authors: A
authors: Mohapatra
authors: Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College and Dr. Prabhakar Kore KLES Hospital, Belgaum, Karnataka 590010, India.
authors: B S
authors: BS
authors: Manjunathswamy
references: BMC Dermatol. 2006 Mar 10;6:3
references: 16526964
references: Postgrad Med J. 1970 May;46(535):276-7
references: 5448375
references: Br J Dermatol. 1969 Feb;81(2):83-8
references: 5767075
references: Arch Intern Med. 1993 Apr 12;153(7):862-5
references: 8466378
references: Br J Dermatol. 2012 Mar;166(3):539-44
references: 22032627
references: Br J Dermatol. 1988 Feb;118(2):223-8
references: 3348967
references: Dermatol Clin. 1997 Jan;15(1):69-78
references: 9001862
references: Indian J Dermatol Venereol Leprol. 2006 Jul-Aug;72(4):315-21
references: 16880586
references: Arch Dermatol. 1993 Aug;129(8):994-8
references: 8352624
references: Acta Derm Venereol. 1994 Mar;74(2):120-3
references: 7911617
references: Int J Dermatol. 2005 Mar;44(3):193-6
references: 15807724
references: Indian J Dermatol. 1972 Jan;17(2):51-6
references: 5039893
references: Autoimmunity. 2004 Jun;37(4):287-90
references: 15518043
references: J Eur Acad Dermatol Venereol. 2011 Jan;25(1):64-7
references: 20456552
references: Acta Dermatovenerol Alp Pannonica Adriat. 2008 Sep;17(3):129-32
references: 18853076
references: Int J Dermatol. 1980 Jun;19(5):237-44
references: 6993382
references: Dermatology. 1994;188(4):269-75
references: 8193398
references: Br J Dermatol. 2012 Dec;167(6):1224-35
references: 22860695
references: J Am Acad Dermatol. 1995 Oct;33(4):621-5
references: 7673496
references: Dermatologica. 1985;171(6):419-23
references: 4092795
references: Br J Dermatol. 1968 Mar;80(3):135-9
references: 5646064
references: Arch Dermatol. 1976 Sep;112(9):1328
references: 999321
references: Int J Dermatol. 1996 Jan;35(1):18-21
references: 8838923
references: Int J Dermatol. 1997 May;36(5):353-5
references: 9199982
references: J Dermatol. 1999 Oct;26(10):653-7
references: 10554431
references: Arch Dermatol. 1977 Jan;113(1):47-52
references: 831622
references: An Bras Dermatol. 2011 Mar-Apr;86(2):241-8
references: 21603806